STAAR Surgical

STAAR® Surgical Company, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 500,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in over 70 countries. Headquartered in Monrovia, CA, conducts operations in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.
Monrovia, US
Size (employees)
336 (est)-6%
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US

STAAR Surgical Office Locations

STAAR Surgical has offices in Monrovia, Nidau and Tustin
Monrovia, US (HQ)
1911 Walker Ave
Nidau, CH
104 Hauptstrasse

STAAR Surgical Data and Metrics

STAAR Surgical Financial Metrics

STAAR Surgical's revenue was reported to be $82.4 m in FY, 2016 which is a 7% increase from the previous period.

Revenue (FY, 2016)

82.4 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

58.4 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(12.1 m)

EBIT (FY, 2016)

(12.7 m)

Market capitalization (23-Jun-2017)

446.2 m

Closing share price (23-Jun-2017)


Cash (31-Dec-2016)

14 m
STAAR Surgical's current market capitalization is $446.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


72.2 m75 m77.1 m82.4 m

Revenue growth, %


Cost of goods sold

21.9 m26.2 m24.4 m24.1 m

Gross profit

50.3 m48.8 m52.7 m58.4 m

Gross profit Margin, %



700 k(8 m)(5.3 m)(12.7 m)

EBIT margin, %


Interest income

59 k51 k50 k3 k

Net Income

398 k(8.4 m)(6.5 m)(12.1 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016


23 m13 m13.4 m14 m

Accounts Receivable

10.7 k11.1 k15.7 k16.3 k


12.5 k15.7 k15.9 k14.8 k

Current Assets

50.1 m44.9 m49.1 m49.9 m


7.4 m10.1 m10.1 m11.8 m


1.8 m1.8 m1.8 m1.8 m

Total Assets

61.9 m58.9 m63 m65.4 m

Accounts Payable

6.3 m6.6 m6.7 m8.3 m

Current Liabilities

18.4 m16.4 m17.9 m21.1 m

Additional Paid-in Capital

170.2 m178.2 m187 m197.7 m

Retained Earnings

(132.1 m)(140.4 m)(147 m)(159.1 m)

Total Equity

38.9 m37.1 m38.8 m37.9 m

Financial Leverage

1.6 x1.6 x1.6 x1.7 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

398 k(8.4 m)(6.5 m)(12.1 m)

Depreciation and Amortization

1.7 m2.1 m2.2 m2.7 m

Accounts Receivable

(2.9 m)(934 k)(5 m)(771 k)


(1.6 m)(3.9 m)327 k1.8 m

Accounts Payable

367 k972 k14 k1 m

Cash From Operating Activities

3.4 m(9.9 m)389 k1 m

Purchases of PP&E

(3.4 m)(4.1 m)(2 m)(3.2 m)

Cash From Investing Activities

(3.4 m)(4.1 m)(2 m)(3.2 m)

Cash From Financing Activities

2.4 m2.5 m4.6 m3 m
USDY, 2016


229 k

Financial Leverage

1.7 x

STAAR Surgical Operating Metrics

FY, 2016

Patents Issued


Patents Pending




STAAR Surgical Market Value History

STAAR Surgical Revenue Breakdown

STAAR Surgical Online and Social Media Presence

STAAR Surgical Company Life and Culture

You may also be interested in